CRABP2 promotes myoblast differentiation and is modulated by the transcription factors MyoD and Sp1 in C2C12 cells

PLoS One. 2013;8(1):e55479. doi: 10.1371/journal.pone.0055479. Epub 2013 Jan 31.

Abstract

Cellular retinoic acid binding protein 2 (CRABP2), a member of a family of specific carrier proteins for Vitamin A, belongs to a family of small cytosolic lipid binding proteins. Our previous study suggested that CRABP2 was involved in skeletal muscle development; however, the molecular function and regulatory mechanism of CRABP2 in myogenesis remained unclear. In this study, we found that the expression of the CRABP2 gene was upregulated during C2C12 differentiation. An over-expression assay revealed that CRABP2 promotes myogenic transformation by regulating the cell cycle during C2C12 differentiation. The region from -459 to -4 bp was identified as the core promoter and contains a TATA box, a GC box and binding sites for the transcription factors MyoD and Sp1. Over-expression, site-directed mutagenesis and EMSA assays indicated that the transcription factors MyoD and Sp1 regulate CRABP2 expression and promote myoblast differentiation in C2C12 cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Differentiation / genetics*
  • Cell Line
  • Gene Expression Regulation
  • Genetic Vectors / genetics
  • Humans
  • Lentivirus / genetics
  • Mice
  • MyoD Protein / metabolism*
  • Myoblasts / cytology*
  • Myoblasts / metabolism*
  • Promoter Regions, Genetic
  • Receptors, Retinoic Acid / genetics*
  • Receptors, Retinoic Acid / metabolism
  • Reproducibility of Results
  • Sp1 Transcription Factor / metabolism*
  • Transcriptional Activation

Substances

  • MyoD Protein
  • Receptors, Retinoic Acid
  • Sp1 Transcription Factor
  • retinoic acid binding protein II, cellular

Grants and funding

This research was supported by the National Key Project (2012CB124706-6, 2011ZX08006-002, 2009CB941604) and the National Natural Science Foundation of China (31171192, 31172182). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.